Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 11, 2005, Pages 2376-2380

  Watanabe, Saiko ^a   Tagawa, Tatsuya ^a   Yamakawa, Ken ^a   Shimabukuro, Michio ^a   Ueda, Shinichiro ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Endothelium; Fatty acids; Insulin resistance; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ASCORBIC ACID; FATTY ACID; HEPARIN; LIPID; LOSARTAN; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PERINDOPRIL; PLACEBO; RENIN;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDOTHELIUM CELL; ENZYME INHIBITION; FOREARM BLOOD FLOW; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

ACETYLCHOLINE; ADULT; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; HEPARIN; HUMANS; LIPIDS; LOSARTAN; MALE; OMEGA-N-METHYLARGININE; PERINDOPRIL; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM; VASODILATION; VASODILATOR AGENTS;

EID: 27644553779     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000187465.55507.85     Document Type: Article

References (26)

1. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for syndrome of insulin resistance. J Clin Invest. 1996;97: 2601-2610.
2. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
3. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab. 2003;88:3236-3240.
4. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M. FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab. 2002;87:2913-2917.
5. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003;52: 2882-2887.
6. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939-1945.
7. Hennig B, Meerarani P, Ramadass P, Watkins BA, Toborek M. Fatty acid-mediated activation of vascular endothelial cells. Metabolism. 2000; 49:1006-1013.
8. Yu HY, Inoguchi T, Kakimoto M, Nakashima N, Imamura M, Hashimoto T, Umeda F, Nawata H. Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase C activity in cultured aortic smooth muscle cells. Diabetologia. 2001;44:614-620.
9. CAPPP study group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/β-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project (CAPPP). Diabetes Care. 2001; 24:2091-2096.
10. LIFE study group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:1004-1010.
11. O'Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, Taylor R. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1999;33:1506-1511.
12. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol. 2000;36: 1461-1466.
13. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001;79:21-29.
14. Ueda S, Wada A, Umemura S. Methodological validity and feasibility of NO clamp research in human resistance vessels. Hypertens Res. 2004; 27:351-357.
15. Petrie JR, Ueda S, Morris AD, Murray LS, Elliott HL, Connell JMC. How reproducible is bilateral forearm venous occlusion plethysmography in man? Br J Clin Pharmacol. 1998;45:131-139.
16. Sugo S, Matsumoto Y, Yamaoka T, Sakurabayashi I. Improved enzymatic method for determining free fatty acids in serum, with use of 3-octenoic acid. Clin Chem. 1990;36:163.
17. Brace R, Godsland I, Walton C, Crook D, Wynn V. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism. 1994;43:1275-1281.
18. Swislocki ALM, Chen Y-DI, Golay A, Chang M-O, Reaven GM. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1987;30:622-626.
19. Kearney MT, Chowienczyk PJ, Brett SE, Sutcliffe A, Ritter JM, Shah AM. Acute haemodynamic effects of lipolysis-induced increase of free fatty acids in healthy men. Clin Sci. 2002;102:495-500.
20. de Man FH, Weverling-Rijnsburger AW, van der Laarse A, Smelt AH, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol. 2000;20:744-750.
21. Chowienczyk PJ, Cockcroft JR, Ritter JM. Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci. 1994;87:45-51.
22. Boden G, Chen X, Ruiz J, White JV, Rossetti L, Mechanism of fatty acid-induced inhibition of glucose uptake J Clin Invest. 1994;93: 2438-2446.
23. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93: 1331-1333.
24. Nielsen S, Halliwill JR. Joyner MJ, Jensen MD. Vascular response to angiotensin II in upper body obesity. Hypertension. 2004;44:435-444.
25. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/ NADPH-oxidases. Cardiovasc Res. 1999;44:215-222.
26. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A. Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res. 2003; 26:953-959.